Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 4Terminated 2Active not recruiting 1

Sponsor Class

OTHER 11NIH 5NETWORK 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Lung Neoplasms 2

Interventions

Radiotherapy 214Cisplatin 180Cyclophosphamide 169Doxorubicin 138Vincristine 127Paclitaxel 125Filgrastim 121Etoposide 104Carboplatin 100Methotrexate 83Gemcitabine 82Docetaxel 78Cytarabine 78Gene Expression Profiling 74Fluorouracil 74Prednisone 71Granulocyte Colony-Stimulating Factor 66Dexamethasone 66Leucovorin 62Polymerase Chain Reaction 47Immunohistochemistry 46Microarray Analysis 40Daunorubicin 38Irinotecan 37Ifosfamide 37Temozolomide 35Cetuximab 33Amplified Fragment Length Polymorphism Analysis 33Peripheral Blood Stem Cell Transplantation 32Mercaptopurine 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × NETWORK × BCG Vaccine × Clear all
NCT00002990 2013-06-12

Surgery and BCG in Treating Patients With Bladder Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
1,288 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00023842 2012-09-24

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
97 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00006352 2012-07-18

Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
453 enrolled
Thoracic

Lung Neoplasms

NCT00003279 2012-03-06

SILVA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
500 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡